Drug Shortage Report for BEPREVE
Report ID | 103041 |
Drug Identification Number | 02456532 |
Brand name | BEPREVE |
Common or Proper name | BEPREVE |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | BEPOTASTINE BESILATE |
Strength(s) | 1.5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 10ml |
ATC code | S01 |
ATC description | L3 not assigned |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-11-15 |
Estimated end date | |
Actual end date | 2020-02-11 |
Shortage status | Resolved |
Updated date | 2020-02-14 |
Company comments | artwork issue |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-14 | French | Compare |
v3 | 2020-02-14 | English | Compare |
v2 | 2020-01-10 | French | Compare |
v1 | 2020-01-10 | English | Compare |
Showing 1 to 4 of 4